4/29/2012. Management of Central Vein Stenoses. Central Venous Stenoses and Occlusions

Size: px
Start display at page:

Download "4/29/2012. Management of Central Vein Stenoses. Central Venous Stenoses and Occlusions"

Transcription

1 Central Venous Stenoses and Occlusions Management of Central Vein Stenoses Robert K. Kerlan Jr. M.D. Professor of Clinical Radiology and Surgery University of California San Francisco Key Questions What is the cause? Is treatment always necessary? What is the best way to treat? UCSF Vascular Symposium April 28, 2012 Central Venous Stenoses and Occlusions Central Venous Stenoses and Occlusions Key Questions What is the cause? Is treatment always necessary? What is the best way to treat? By far, the most common cause of central venous stenoses and occlusions in the dialysis patient is previous line placement. Additional factors Entrapment (3 to 80 / 1000 people) 1

2 Venous Catheters and Stenoses Location of Lines Hernandez et al. J Am Soc Nephrol 1998;9: Prospective trial of 42 consecutive dialysis patients with subclavian catheter insertion 52% developed 6 months Multivariate analysis revealed association with Number of lines Duration of lines Line infection Subclavian > Jugular 42% vs 10% Schillinger et al Neph Dial Trans 1991;6:722 83% vs 36% MacRae et al. ASAIO J 2005;51:71 Left Jugular > Right Jugular Central Venous Stenoses are Caused by Lines Central Venous Stenoses and Occlusions The optimal solution for CVSO is to place hemodialysis access prior to initiation of dialysis The only winning move is not to play! WOPR Computer War Games 1983 Key Questions What is the cause? Is treatment always necessary? What is the best way to treat? 2

3 CVSO and Dialysis Access Failure Is Treatment Always Necessary? 15% to 25% of patients with dialysis access failure have CVSO as the only identifiable hemodynamic cause Levit et al. Radiology 2006;238: patients with 86 CVS No patients had arm swelling All patients had access dysfunction 24/86 CVS were not treated These patients had peripheral lesions treated to improve access function 62/86 CVS were treated Follow-up venograms of CVS were analyzed Is Treatment Always Necessary? Is Treatment Always Necessary? Levit et al. Radiology 2006;238:1051 Untreated group 12/24 (50%) CVS s had no f/u venography 12/24 (50%) CVS s had repeat venograms 4 improved, 4 stable, 4 progression No untreated CVS progressed to Symptoms Occlusion Levit et al. Radiology 2006;238:1051 Treated group 36/62 (58%) CVSs had no follow-up venograms 26/62 (42%) had repeat venograms 3 improved, 0 stable, 23 progression (mean diameter reduction reduction) Treated CVS progressed to Arm swelling (1) Additional CVS (4) Lesion requiring stent placement (4) 3

4 Is Treatment Always Necessary? Central Venous Stenoses and Occlusions Maybe not In patients who are minimally symptomatic and have identifiable peripheral causes for access failure consider: Treating the peripheral lesions And not treating CVSO Key Questions What is the cause? Is treatment always necessary? What is the best way to treat? Audience Question Treatment of CVSO What is the optimal way to treat a central venous stenosis in a dialysis patient? Balloon Angioplasty 1. Balloon angioplasty 2. Bare metal stent 3. Stent graft 4. Cutting balloon 5. Surgical bypass 35% 19% 35% 10% Stents Surgical Bypass 0%

5 Treatment of CVSO What is the best way to treat? Balloon Angioplasty Stents Surgical Bypass K/DOQI Guideline 20 Percutaneous transluminal angioplasty with or without stent placement is considered the preferred approach to treat central venous stenosis Guideline 20 Am J Kidney Dis 2001;37:s137-s181 Balloon Angioplasty of CVSO Balloon Angioplasty of CVSO Series (year) n 1-year Primary Patency 2-year Primary Patency 1-year Secondary Patency 2-year Secondary Patency Glanz (1987) 30 35% 10% - - Wisselink (1993) 15 36% 0% 86% 66% Quinn (1995) 10 12% - 100% - Money (1995) 26 7% Lumsden (1997) 17 17% Surowiec (2004) 35 43% 0% 80% 64% 5

6 Treatment of CVSO Treatment of CVSO Balloon Angioplasty Stents Surgical Bypass K/DOQI Guideline 20 Stents should be placed for elastic lesions recurring within three months following initially successful balloon angioplasty Guideline 20 Am J Kidney Dis 2001;37:s137-s181 Stents for CVSO Stents for CVSO 6

7 Bare Metal Stents for CVSO Bare Metal Stents for CVSO Haage et al. Radiology 1999;212: patients Primary Wallstent placement Maya ID et al. Semin Dial 2007;20:78 23 patients with stent placement for failed PTA Wallstents and Luminex stents Stents vs PTA for CVSO Bakken AM et al. J Vasc Surg 2007;45:776 Retrospective cohort study of 73 patients Primary high-pressure PTA 47 patients Primary Wallstent 26 patients Stents vs PTA for CVSO Bakken AM et al. J Vasc Surg 2007;45:776 Retrospective cohort study of 73 patients Primary high-pressure PTA 47 patients Primary Wallstent 26 patients Primary Patency P=.48 Primary Assisted Patency P=.08 7

8 Stents vs PTA for CVSO Stents vs PTA for CVSO Bakken AM et al. J Vasc Surg 2007;45:776 Retrospective cohort study of 73 patients Primary high-pressure PTA 47 patients Primary Wallstent 26 patients Hemodialysis Access Survival P=.13 Bare metal stents offer no advantage to balloon angioplasty in the treatment of central venous stenoses Stents may be useful in selected cases following recanalization of an occluded segment (speculative) Bare metal stents are useful to rescue a failed balloon angioplasty Stent-grafts have better patency than PTA in venous outflow stenoses complicating dialysis access grafts Stent-grafts perform substantially better than bare metal stents in TIPS Haskal ZJ et al. NEJM 2010;362: Bureau C et al Liver Int 2007;27:

9 Stent-grafts perform better than bare metal stents in recurrent cephalic arch stenoses Whether stent grafts will outperform bare-metal stents and balloon angioplasty is unknown P=.0023 Microtrauma induced by stent is likely a contributing issue Shemesh D et al J Vasc Surg 2008;48: Repetitive motion from arms and shoulders lead to endothelial microtrauma inducing an inflammatory response resulting in intimal hyperplasia Stent grafts have greatly improved this problem in TIPS where diaphragmatic motion was responsible for the microtrauma Will this be true in CVSO??? 9

10 Stent-Grafts for CVSO? 42 Viabahn stents in 30 patients Mean f/u 705 days Primary 1-yr 67% 2-yrs 45% Jones RG et al JVIR 2011;22:1240 Balloon Angioplasty Stents Treatment of CVSO Surgical Bypass Possible, but few patients are suitable Axillary vein to right atrium bypass 9 patients, 100% success, mean patency 15.4 months El-Sabrout RA, Duncan JM. J Vasc Surg 1999;29: Mickley V. Eur J Endovasc Surg 2006;32: Surgical Bypass Subclavian artery to right atrium bypass Case report Mickley V. Nephrol Dial Transplant. 1996;11:

11 CVSO in the Dialysis Patient: Conclusions Best treatment is to avoid placement of dialysis lines Create fistula within a year of anticipated dialysis Balloon angioplasty performs equivalent to bare metal stents Both treatments are flawed Stent-grafts may be better, but scientific evaluation has not been performed 11

ASDIN 9th Annual Scientific Meeting

ASDIN 9th Annual Scientific Meeting Stent Graft Placement is Best for Cephalic Arch and Central Vein Stenosis Dheeraj K. Rajan MD, FRCPC, FSIR Head - Division of Vascular and Interventional Radiology University of Toronto University Health

More information

Case #1. Case #1- Possible codes. Unraveling the -59 modifier. Principles of Interventional. CASE 1: Simple angioplasty

Case #1. Case #1- Possible codes. Unraveling the -59 modifier. Principles of Interventional. CASE 1: Simple angioplasty Unraveling the -59 modifier Principles of Interventional Coding Donald Schon, MD, FACP Debra Lawson, CPC, PCS Distinct or independent from other services performed on the same day Normally not reported

More information

HeRO. Jeffrey H. Lawson, M.D., Ph.D. Departments of Surgery and Pathology Duke University Medical Center Durham, North Carolina

HeRO. Jeffrey H. Lawson, M.D., Ph.D. Departments of Surgery and Pathology Duke University Medical Center Durham, North Carolina HeRO Jeffrey H. Lawson, M.D., Ph.D. Departments of Surgery and Pathology Duke University Medical Center Durham, North Carolina Disclosures Consulting, Clinical Trials and Opinion Hemosphere Ark Therapeutics

More information

COVERA Vascular Covered Stents in the Management of Dysfunctional AV Access

COVERA Vascular Covered Stents in the Management of Dysfunctional AV Access COVERA Vascular Covered Stents in the Management of Dysfunctional AV Access Bart L. Dolmatch, M.D., FSIR Palo Alto Medical Foundation Mountain View, CA USA This presentation is being made on behalf of

More information

CATHETER REDUCTION. Angelo N. Makris, M.D. Medical Director Chicago Access Care

CATHETER REDUCTION. Angelo N. Makris, M.D. Medical Director Chicago Access Care CATHETER REDUCTION Angelo N. Makris, M.D. Medical Director Chicago Access Care Objectives Discuss tools/techniques proven to improve AVF rates & decrease catheter rates Implement a change process in your

More information

Jimmy Wei Hwa Tan, Surg, MD

Jimmy Wei Hwa Tan, Surg, MD Jimmy Wei Hwa Tan, Surg, MD Director, Department of Surgery Chief, Department of Cardiovascular Surgery Tainan An-Nan Municipal Hospital, China Medical University, Taiwan Disclosure I have the following

More information

Interventions for AV-Shunt stenosis: What works best PTA, Stent or DCB?

Interventions for AV-Shunt stenosis: What works best PTA, Stent or DCB? Interventions for AV-Shunt stenosis: What works best PTA, Stent or DCB? Martin Forlee Vascular Surgeon Cape Town Disclosure Speaker name: Martin Forlee I have the following potential conflicts of interest

More information

Vascular Surgery and Transplant Unit University of Catania. Pierfrancesco Veroux

Vascular Surgery and Transplant Unit University of Catania. Pierfrancesco Veroux Vascular Surgery and Transplant Unit University of Catania Pierfrancesco Veroux Bologna-Palazzo dei Congressi, 23 Ottobre 2017 Disclosure Speaker name: Prof. Pierfrancesco Veroux I have the following potential

More information

Lutonix in AV fistula and Early look AV IDE trial data

Lutonix in AV fistula and Early look AV IDE trial data Lutonix in AV fistula and Early look AV IDE trial data Jackie P Ho Dept of Cardiac, Thoracic & Vascular Surgery National University of Singapore NUHS, Singapore Lutonix in AV fistula and final AV IDE trial

More information

Prospective, randomized controlled study of paclitaxel-coated versus plain balloon angioplasty for the treatment of failing dialysis access

Prospective, randomized controlled study of paclitaxel-coated versus plain balloon angioplasty for the treatment of failing dialysis access Prospective, randomized controlled study of paclitaxel-coated versus plain balloon angioplasty for the treatment of failing dialysis access Disclosure Speaker name:... I have the following potential conflicts

More information

Role of Covered Stents and Drug Eluting Balloons In Dialysis Access

Role of Covered Stents and Drug Eluting Balloons In Dialysis Access Role of Covered Stents and Drug Eluting Balloons In Dialysis Access Joseph Habib, MD, FACS Assistant Professor Department of Surgery Division of Vascular and Endovascular Surgery University of Florida

More information

Lutonix AV Clinical Trial

Lutonix AV Clinical Trial Long Term Effects of LUTONIX 035 DCB Catheter Interim 24 Month Results Scott O. Trerotola, MD, for the Lutonix AV Investigators Stanley Baum Professor of Radiology Professor of Radiology in Surgery Associate

More information

IN.PACT AV Access IDE Study Full Baseline Data. Robert Lookstein, MD MHCDL New York, NY On Behalf of the IN.PACT AV ACCESS Investigators

IN.PACT AV Access IDE Study Full Baseline Data. Robert Lookstein, MD MHCDL New York, NY On Behalf of the IN.PACT AV ACCESS Investigators IN.PACT AV Access IDE Study Full Baseline Data Robert Lookstein, MD MHCDL New York, NY On Behalf of the IN.PACT AV ACCESS Investigators Disclosures Speaker name: Robert Lookstein, MD... I have the following

More information

The Role of LUTONIX 035 DCB in AV Fistula Dysfunction Management in our Practice

The Role of LUTONIX 035 DCB in AV Fistula Dysfunction Management in our Practice The Role of LUTONIX 035 DCB in AV Fistula Dysfunction Management in our Practice Dr Kate Steiner Consultant Interventional Radiologist East and North Hertfordshire NHS Trust Disclosure Speaker name: Dr

More information

Since the initiation of hemodialysis, multiple inventions

Since the initiation of hemodialysis, multiple inventions Special Feature Stent Graft for Nephrologists: Concerns and Consensus Loay Salman and Arif Asif Division of Nephrology, Section of Interventional Nephrology, University of Miami Miller School of Medicine,

More information

Occlusion: A New Technique Antegrade wiring i with retrograde ballooning and stenting

Occlusion: A New Technique Antegrade wiring i with retrograde ballooning and stenting How To Treat Resistant Central Venous Occlusion: A New Technique Antegrade wiring i with retrograde ballooning and stenting Dafsah A Juzar T. Santoso National Heart Center, Harapan Kita, & Medistra Hospital

More information

Lutonix AV Clinical Trial

Lutonix AV Clinical Trial Long Term Effects of LUTONIX 035 DCB Catheter Interim 24 Month Results Ta-Wei Su MD Vascular surgery CGMH Taiwan Disclosure I have the following potential conflicts of interest to report: Consulting Employment

More information

ENDOVASCULAR TREATMENT OF MALFUNCTIONING HAEMODIALYSIS GRAFTS/FISTULAS. Dr R Uberoi Interventional Radiologist John Radcliffe hospital Oxford.

ENDOVASCULAR TREATMENT OF MALFUNCTIONING HAEMODIALYSIS GRAFTS/FISTULAS. Dr R Uberoi Interventional Radiologist John Radcliffe hospital Oxford. ENDOVASCULAR TREATMENT OF MALFUNCTIONING HAEMODIALYSIS GRAFTS/FISTULAS Dr R Uberoi Interventional Radiologist John Radcliffe hospital Oxford. Stenosis Stenosis Native fistula/grafts. Radio-cephalic 55-75%

More information

Percutaneous transluminal angioplasty in the treatment of stenosis of hemodialysis arteriovenous fistulae: our experience

Percutaneous transluminal angioplasty in the treatment of stenosis of hemodialysis arteriovenous fistulae: our experience Percutaneous transluminal angioplasty in the treatment of stenosis of hemodialysis arteriovenous fistulae: our experience Poster No.: C-3355 Congress: ECR 2010 Type: Scientific Exhibit Topic: Interventional

More information

*PTA Failure: Recoil >30% stenosis or more than 2 PTA s within 3 mo. Bart Dolmatch, MD

*PTA Failure: Recoil >30% stenosis or more than 2 PTA s within 3 mo. Bart Dolmatch, MD The views presented reflect those of the author/presenter and do not necessarily reflect those of ASDIN nor serve as an endorsement of safety, efficacy or applicability of said procedure. the Endovascular

More information

Disclosures. Consultant/Independent Contractor: B Braun, Teleflex, MedComp, Cook, Bard, WL Gore Royalty: Cook, Teleflex

Disclosures. Consultant/Independent Contractor: B Braun, Teleflex, MedComp, Cook, Bard, WL Gore Royalty: Cook, Teleflex Disclosures Consultant/Independent Contractor: B Braun, Teleflex, MedComp, Cook, Bard, WL Gore Royalty: Cook, Teleflex DCB in Hemodialysis Access Scott Trerotola, MD 2016: 50 th birthday of the AVF History

More information

Introduction to the Native Arteriovenous Fistula: A primer for medical students and radiology residents

Introduction to the Native Arteriovenous Fistula: A primer for medical students and radiology residents Introduction to the Native Arteriovenous Fistula: A primer for medical students and radiology residents Jesus Contreras, D.O. PGY-4 John Yasmer, D.O. Department of Radiology No Disclosures Objectives Introduce

More information

The HeRO Graft. Shawn M. Gage, PA Division of Vascular Surgery Duke University Medical Center

The HeRO Graft. Shawn M. Gage, PA Division of Vascular Surgery Duke University Medical Center The HeRO Graft Shawn M. Gage, PA Division of Vascular Surgery Duke University Medical Center Faculty Disclosure I disclose the following financial relationships: CryoLife/Hemosphere, Inc. & W.L. Gore and

More information

Regardless of whether you are a vascular surgeon,

Regardless of whether you are a vascular surgeon, C A S E R E P O R T The Versatility of the GORE VIABAHN Endoprosthesis Several case reports highlighting its unique design and why it is a valuable tool for the interventionist. BY PETER WAYNE, MD Regardless

More information

COVERA Vascular Covered Stents Innovation in AV Access

COVERA Vascular Covered Stents Innovation in AV Access IL0118 Rev.0 1 COVERA Vascular Covered Stents Innovation in AV Access Dheeraj Rajan, MD, FRCPC, FSIR Head and Associate Professor, Division of Vascular & Interventional Radiology Department of Medical

More information

2006 NKF-DOQI Guidelines Preferred Vascular Access Order 1. Radiocephalic (wrist) fistula 2. Brachiocephalic (elbow) fistula 3. Basilic vein transposi

2006 NKF-DOQI Guidelines Preferred Vascular Access Order 1. Radiocephalic (wrist) fistula 2. Brachiocephalic (elbow) fistula 3. Basilic vein transposi Stage 5 Chronic Kidney Disease Assessing the Results of AV Access: Realistic Outcomes in 2009 Sean P. Roddy, MD Albany, NY Defined as a GFR

More information

UC SF. End Stage Renal Disease. National Kidney Foundation Dialysis Outcomes Quality Initiative (K/DOQI) BUT-- No Cephalic Vein What s Next

UC SF. End Stage Renal Disease. National Kidney Foundation Dialysis Outcomes Quality Initiative (K/DOQI) BUT-- No Cephalic Vein What s Next No Cephalic Vein What s Next End Stage Renal Disease Charles Eichler MD Clinical Professor of Surgery Division of Vascular Surgery UCSF April 5, 2014 Population of patients with ESRD growing rapidly -

More information

AV ACESS COMPLICATIONS. Ass. Prof. Dr. Habas

AV ACESS COMPLICATIONS. Ass. Prof. Dr. Habas AV ACESS COMPLICATIONS Ass. Prof. Dr. Habas COMPLICATION AVF IS CONSIDERED A MINOR PROCEDURE INCIDENCE OF COMPLICATION- 20-27% MANY A COMPLICATION LEADS TO FAILURE OF FISTULA LOSS OF SITE AND VEIN FOR

More information

Access Preservation: Recurrent Central Venous Stenosis, Pacemaker Wires and other Nightmares. Who am I? Disclosures

Access Preservation: Recurrent Central Venous Stenosis, Pacemaker Wires and other Nightmares. Who am I? Disclosures Access Preservation: Recurrent Central Venous Stenosis, Pacemaker Wires and other Nightmares Jason Burgess, MD RVT Surgical Specialists of Charlotte CMC-Mercy Charlotte, NC Disclosures Gore Vascular- Consultant

More information

Efficacy of covered stent placement for central venous occlusive disease in hemodialysis patients

Efficacy of covered stent placement for central venous occlusive disease in hemodialysis patients From the Eastern Vascular Society Efficacy of covered stent placement for central venous occlusive disease in hemodialysis patients Javier E. Anaya-Ayala, MD, a,b Christopher J. Smolock, MD, a Benjamin

More information

HD Scanning: Velocities and Volume Flow

HD Scanning: Velocities and Volume Flow HD Scanning: Velocities and Volume Flow Non-Invasive Lab Symposium West Orange, NJ April 27, 2018 Volume Flow Cindy Sturt, MD, FACS, RVT 500,000 Americans on dialysis 20-25% annual mortality 65% 5 year

More information

Bare Metal Stents vs Stent Grafts

Bare Metal Stents vs Stent Grafts Bare Metal Stents vs Stent Grafts ASDIN 12th Annual Scientific Meeting Phoenix, AZ, February 20, 2016 Dirk Hentschel, MD Director, Interventional Nephrology Brigham and Women s Hospital Disclosure Consultant:

More information

Thoughtful vs. Dogmatic

Thoughtful vs. Dogmatic Debate on Balloon Assisted Maturation The Biology is Wrong: BAM Won t Work BAM Dr. Rapp Debate BIVF Dr. Lawson Jeffrey H. Lawson, M.D., Ph.D. Departments of Surgery and Pathology Duke University Medical

More information

Interventional Treatment VTE: Radiologic Approach

Interventional Treatment VTE: Radiologic Approach Interventional Treatment VTE: Radiologic Approach Hae Giu Lee, MD Professor, Dept of Radiology Seoul St. Mary s Hospital The Catholic University of Korea Introduction Incidence High incidence: 250,000-1,000,000/year

More information

Technical Aspects for Treating AV Dialysis Fistulae with the IN.PACT DCB. Andrew Holden Auckland Hospital Auckland, New Zealand

Technical Aspects for Treating AV Dialysis Fistulae with the IN.PACT DCB. Andrew Holden Auckland Hospital Auckland, New Zealand Technical Aspects for Treating AV Dialysis Fistulae with the IN.PACT DCB Andrew Holden Auckland Hospital Auckland, New Zealand LINC 2017 26 th January 2017 Disclosure Speaker name: Andrew Holden I have

More information

Endovascular therapy of central vein stenosis in hemodialysis patients. Venous chimney graft to preserve residual jugular vein

Endovascular therapy of central vein stenosis in hemodialysis patients. Venous chimney graft to preserve residual jugular vein Endovascular therapy of central vein stenosis in hemodialysis patients. Venous chimney graft to preserve residual jugular vein Poster No.: C-2358 Congress: ECR 2015 Type: Scientific Exhibit Authors: R.

More information

What s on the Horizon in Dialysis Access? Libby Watch, MD, FACS Miami Cardiac & Vascular Institute

What s on the Horizon in Dialysis Access? Libby Watch, MD, FACS Miami Cardiac & Vascular Institute What s on the Horizon in Dialysis Access? Libby Watch, MD, FACS Miami Cardiac & Vascular Institute Disclosures No relevant disclosures Employee Advanced Access Care Dialysis Work 5 operating surgeons 3

More information

Percutaneously Inserted AngioVac Suction Thrombectomy for the Treatment of Filter-Related. Iliocaval Thrombosis

Percutaneously Inserted AngioVac Suction Thrombectomy for the Treatment of Filter-Related. Iliocaval Thrombosis Percutaneously Inserted AngioVac Suction Thrombectomy for the Treatment of Filter-Related Iliocaval Thrombosis Faiz D. Francis, DO; Gianvito Salerno, MD; Sabbah D. Butty, MD Abstract In the setting of

More information

The Art of Angioplasty

The Art of Angioplasty The Art of Angioplasty Achieving and Defining Success Thomas M. Vesely, MD Saint Louis, Missouri Dr. Vesely is a consultant for: W.L. Gore & Associates Lutonix Imaging the Vascular Access Circuit A well

More information

LUTONIX AV Clinical Trial

LUTONIX AV Clinical Trial LUTONIX AV Clinical Trial A Prospective, Global, Multicenter, Randomized, Controlled Study Comparing LUTONIX 035 AV Drug Coated Balloon PTA Catheter vs. Standard Balloon PTA Catheter for the Treatment

More information

Decreased Incidence of Clotted AV Access in Hemodialysis Patients after the Implementation of Follow up Program

Decreased Incidence of Clotted AV Access in Hemodialysis Patients after the Implementation of Follow up Program Global Journal of Health Science; Vol. 8, No. 10; 2016 ISSN 1916-9736 E-ISSN 1916-9744 Published by Canadian Center of Science and Education Decreased Incidence of Clotted AV Access in Hemodialysis Patients

More information

Salvaging prosthetic dialysis fistulas with stents: Forearm versus upper arm grafts

Salvaging prosthetic dialysis fistulas with stents: Forearm versus upper arm grafts From the Society for Clinical Vascular Surgery Salvaging prosthetic dialysis fistulas with stents: Forearm versus upper arm grafts Stephen Kolakowski, Jr, MD, Matthew J. Dougherty, MD, and Keith D. Calligaro,

More information

First experience with DCB for treatment of dialysis access stenosis The Greek experience

First experience with DCB for treatment of dialysis access stenosis The Greek experience First experience with DCB for treatment of dialysis access stenosis The Greek experience D Karnabatidis Department of Interventional Radiology Patras University Hospital Patras, Greece Background Vessel

More information

Use of PTFE Stent Grafts for Hemodialysis-related Central Venous Occlusions: Intermediate-Term Results

Use of PTFE Stent Grafts for Hemodialysis-related Central Venous Occlusions: Intermediate-Term Results Cardiovasc Intervent Radiol (2011) 34:949 957 DOI 10.1007/s00270-010-0019-4 CLINICAL INVESTIGATION Use of PTFE Stent Grafts for Hemodialysis-related Central Venous Occlusions: Intermediate-Term Results

More information

Recurrent lesions in AV access & Initial DCB experience in India

Recurrent lesions in AV access & Initial DCB experience in India Recurrent lesions in AV access & Initial DCB experience in India Dr. Virender K Sheorain Consultant Interventional Radiologist Medanta-The Medicity Hospital Gurgaon, INDIA Disclosure Speaker name:... I

More information

Interventional Treatment for Complete Occlusion of Arteriovenous Shunt: Our Experience in 39 cases

Interventional Treatment for Complete Occlusion of Arteriovenous Shunt: Our Experience in 39 cases Chin J Radiol 2003; 28: 137-142 137 Interventional Treatment for Complete Occlusion of Arteriovenous Shunt: Our Experience in 39 cases SHE-MENG CHENG SUK-PING NG FEI-SHIH YANG SHIN-LIN SHIH Department

More information

Outcomes Of Combined Rheolytic And Rotational Mechanical Thrombectomy For Total Access Circuit Thrombosis In Hemodialysis Patients

Outcomes Of Combined Rheolytic And Rotational Mechanical Thrombectomy For Total Access Circuit Thrombosis In Hemodialysis Patients Outcomes Of Combined Rheolytic And Rotational Mechanical Thrombectomy For Total Access Circuit Thrombosis In Hemodialysis Patients Nicholas Petruzzi, MD Raphael Cohen, MD Mark Mantell, MD Timothy W. Clark,

More information

Turbo-Power. Laser atherectomy catheter. The standard. for ISR

Turbo-Power. Laser atherectomy catheter. The standard. for ISR Turbo-Power Laser atherectomy catheter The standard for ISR Vaporize the ISR challenge In-stent restenosis (ISR) Chance of recurring 7 115,000 + /year (U.S.) 1-6 Repeated narrowing of the arteries after

More information

All arteriovenous access circuits, whether native vein

All arteriovenous access circuits, whether native vein Summary of the Gore REVISE Clinical Study This nationwide study reports on the safety and effectiveness of the GORE VIHN Endoprosthesis for the treatment of stenoses and thrombotic occlusions involving

More information

Robert W. Fincher, DO The Ritz-Carlton, Dove Mountain Marana, Arizona February 7th, 2015

Robert W. Fincher, DO The Ritz-Carlton, Dove Mountain Marana, Arizona February 7th, 2015 Robert W. Fincher, DO The Ritz-Carlton, Dove Mountain Marana, Arizona February 7th, 2015 Disclosure I have nothing to disclose Randomized Controlled Studies In SFA Technology: What s The Best Tool For

More information

Managing the Failing Dialysis Permacath: Results from a 5-year Retrospective Analysis

Managing the Failing Dialysis Permacath: Results from a 5-year Retrospective Analysis Interventional Original Article Managing the Failing Dialysis Permacath: Results from a 5-year Retrospective Analysis Panagiotis M. Kitrou 1, Panagiotis Papadimatos 1, Konstantinos Katsanos 1, Stavros

More information

Disclosures. Iliac Stenting: How could I mess this up? Surgery vs. Stenting: Gold Standard?

Disclosures. Iliac Stenting: How could I mess this up? Surgery vs. Stenting: Gold Standard? Disclosures Boston Scientific, Medical Advisory Board Endologix Corp., Consultant and trainer, AFX Aorto-Iliac Disease: Bare Metal, Covered or Stent Grafts How I Decide John S. Lane III MD, FACS Professor

More information

Angioplasty remains the most common method

Angioplasty remains the most common method When AVF Angioplasty Fails Defining procedural success and overcoming common problems. By Thomas M. Vesely, MD Angioplasty remains the most common method of treating obstructive vascular stenoses associated

More information

(70%) 11 (18%) ( P

(70%) 11 (18%) ( P Angioplasty with stent graft versus bare stent for recurrent cephalic arch stenosis in autogenous arteriovenous access for hemodialysis: A prospective randomized clinical trial David Shemesh, MD, a Ilya

More information

Thrombectomy, open, arteriovenous fistula without revision, autogenous or nonautogenous dialysis graft (separate procedure)

Thrombectomy, open, arteriovenous fistula without revision, autogenous or nonautogenous dialysis graft (separate procedure) Dialysis Vascular Access Coverage, Coding and Reimbursement Overview Hospital Outpatient 2019 Edition All Reimbursement Amounts are Listed at ational Unadjusted Medicare Rates and Do ot Include the 2%

More information

Proven Performance Through Innovative Design *

Proven Performance Through Innovative Design * Proven Performance Through Innovative Design * Deliver Our Next Generation AV Covered Stent Results The COVERA Vascular Covered Stent builds upon proven technologies from the category leader in AV Access.

More information

Why Can't I Cannulate This Fistula? Fistula Immaturity: The Simple But Critical Steps for a Functioning (Mature) AVF

Why Can't I Cannulate This Fistula? Fistula Immaturity: The Simple But Critical Steps for a Functioning (Mature) AVF Why Can t I Cannulate This Access? Steven J. Bander M.D. Adjunct Professor of Nephrology St. Louis University Director, Vascular Access Center, St. Luke s Hospital Saint Louis, MO Why Can't I Cannulate

More information

AVF Prevalence. Local elastase to aid fistula maturation. I have nothing to disclose

AVF Prevalence. Local elastase to aid fistula maturation. I have nothing to disclose Local elastase to aid fistula maturation Warren Gasper MD UCSF Vascular Surgery Fellow 2013 UCSF Vascular Symposium I have nothing to disclose AVF Prevalence 60.6% (April 2012) Fistula First Initiative

More information

The recent United States Renal Data System

The recent United States Renal Data System Maintenance of Hemodialysis ccess With Stents and Covered Stents Hemodialysis access maintenance advances beyond angioplasty. Y RT L. DOLMTCH, MD The recent United States Renal Data System report 1 shows

More information

Current Status of DCB Experience with Non- Femoropopliteal Applications (Dialysis, Tibial, Venous)

Current Status of DCB Experience with Non- Femoropopliteal Applications (Dialysis, Tibial, Venous) Current Status of DCB Experience with Non- Femoropopliteal Applications (Dialysis, Tibial, Venous) Saher Sabri, MD University of Virginia Health System Charlottesville, Virginia Dialysis vascular access

More information

Konstantinos Katsanos, MSc, MD, PhD, EBIR

Konstantinos Katsanos, MSc, MD, PhD, EBIR Konstantinos Katsanos, MSc, MD, PhD, EBIR Interventional Radiologist Patras University Hospital, Rion, Greece & Guy s and St. Thomas Hospitals, London, UK Honoraria from MEDTRONIC, BOSTON SCI Research

More information

Few occlusive problems in arteriovenous access

Few occlusive problems in arteriovenous access Treatment of VG Venous nastomotic Stenosis Clinical indicators and treatment techniques for this common cause of arteriovenous graft failure. y art L. Dolmatch, MD Few occlusive problems in arteriovenous

More information

Treatment of superior vena cava obstruction secondary to pacemaker wires with balloon venoplasty and insertion of metallic stents

Treatment of superior vena cava obstruction secondary to pacemaker wires with balloon venoplasty and insertion of metallic stents European Heart Journal (2002) 23, 1465 1470 doi:10.1053/euhj.2002.3260, available online at http://www.idealibrary.com on Treatment of superior vena cava obstruction secondary to pacemaker wires with balloon

More information

Thoracic Outlet Syndrome

Thoracic Outlet Syndrome Disclosures None relevant to this discussion The Management of Thoracic Outlet Syndrome: Acute Charles Eichler MD Professor, Department of Surgery Division of Vascular and Endovascular Surgery University

More information

The word stent originates in the dentistry literature to

The word stent originates in the dentistry literature to In-Depth Review Stent Placement in Hemodialysis Access: Historical Lessons, the State of the Art and Future Directions Alexander Yevzlin* and Arif Asif *Department of Medicine, Section of Interventional

More information

Juxta-anastomotic stenoses: angioplasty or surgery (or when/why should we wait)?

Juxta-anastomotic stenoses: angioplasty or surgery (or when/why should we wait)? Juxta-anastomotic stenoses: angioplasty or surgery (or when/why should we wait)? Richard Shoenfeld MD, FSIR, FAHA The Access Center at West Orange West Orange, New Jersey USA SEDAV 2015 Madrid November

More information

Right atrial bypass grafting for central venous obstruction associated with dialysis access: Another treatment option

Right atrial bypass grafting for central venous obstruction associated with dialysis access: Another treatment option Right atrial ing for central venous obstruction associated with dialysis access: Another treatment option Rafik A. El-Sabrout, MD, FRCS, and J. Michael Duncan, MD, Houston, Tex Purpose: Central venous

More information

Qizhuang Jin. Renal Division, Department of Medicine, Peking University First Hospital, Peking University Institute of Nephrology, Beijing, China

Qizhuang Jin. Renal Division, Department of Medicine, Peking University First Hospital, Peking University Institute of Nephrology, Beijing, China Safety and Efficacy of the Paclitaxel Releasing Peripheral Balloon Dilatation Catheter (APERTO OTW ) for Arteriovenous Fistulae Stenosis: a Prospective, Multicenter, Randomized Controlled Trial APERTO

More information

Recanalization Techniques: Sharp Needle Recanalization. Recanalization Techniques: Sharp Needle Recanalization

Recanalization Techniques: Sharp Needle Recanalization. Recanalization Techniques: Sharp Needle Recanalization Recanalization of Occluded Central Veins When Conventional Methods Failed: Abigail Falk, MD, FSIR American Access Care New York, NY Conventional Methods of Recanalization Directional 0.035 and 0.018 Guidewires

More information

Which Stent Is Best for Various Femoropopliteal Anatomy? 2018 Pacific Northwest Endovascular Conference June 15-26, 2018 Seattle, WA

Which Stent Is Best for Various Femoropopliteal Anatomy? 2018 Pacific Northwest Endovascular Conference June 15-26, 2018 Seattle, WA Which Stent Is Best for Various Femoropopliteal Anatomy? 2018 Pacific Northwest Endovascular Conference June 15-26, 2018 Seattle, WA Brian DeRubertis, MD, FACS Associate Professor of Surgery UCLA Division

More information

Merits and demerits of DES, DEB or covered stent in lower extremity arterial occlusive disease 성균관의과대학삼성서울병원순환기내과최승혁

Merits and demerits of DES, DEB or covered stent in lower extremity arterial occlusive disease 성균관의과대학삼성서울병원순환기내과최승혁 Merits and demerits of DES, DEB or covered stent in lower extremity arterial occlusive disease 성균관의과대학삼성서울병원순환기내과최승혁 Contents DES in SFA DES in BTK DEB in SFA DEB in BTK Current status of covered stent

More information

Thoracic Central Venous Obstruction (T-CVO) A New Look at an Old Problem. (This is what we say about T-CVO!)

Thoracic Central Venous Obstruction (T-CVO) A New Look at an Old Problem. (This is what we say about T-CVO!) Thoracic Central Venous Obstruction (T-CVO) These are ALL examples of T-CVO Paget- Schroetter Syndrome A New Look at an Old Problem Bart Dolmatch, MD, FSIR but each one is a different Cellulitis in swollen

More information

A Case for Mandatory Routine Graft Surveillance of lower extremity bypass grafts. Avishai Meyer UCHSC resident, Surgery May 8, 2006

A Case for Mandatory Routine Graft Surveillance of lower extremity bypass grafts. Avishai Meyer UCHSC resident, Surgery May 8, 2006 A Case for Mandatory Routine Graft Surveillance of lower extremity bypass grafts Avishai Meyer UCHSC resident, Surgery May 8, 2006 Outline: Definition Background of terms and studies U/S surveillance What

More information

MIHÁLY TAPOLYAI, MD, FASN, FACP Associate Professor, Louisiana State University; Shreveport, Louisiana, USA Associate Professor; University of Hawai

MIHÁLY TAPOLYAI, MD, FASN, FACP Associate Professor, Louisiana State University; Shreveport, Louisiana, USA Associate Professor; University of Hawai MIHÁLY TAPOLYAI, MD, FASN, FACP Associate Professor, Louisiana State University; Shreveport, Louisiana, USA Associate Professor; University of Hawai i Postgraduate Training Program at Chubu Hospital, Okinawa,

More information

John E. Campbell, MD Assistant Professor of Surgery and Medicine Department of Vascular Surgery West Virginia University, Charleston Division

John E. Campbell, MD Assistant Professor of Surgery and Medicine Department of Vascular Surgery West Virginia University, Charleston Division John E. Campbell, MD Assistant Professor of Surgery and Medicine Department of Vascular Surgery West Virginia University, Charleston Division John Campbell, MD For the 12 months preceding this CME activity,

More information

Should We Be More Aggressive in the Treatment of Acute DVT?

Should We Be More Aggressive in the Treatment of Acute DVT? DISCLOSURES Consultant Penumbra, Inc. UCSF Vascular Surgery Symposium April 6, 2017 K. Pallav Kolli, MD Assistant Professor of Clinical Radiology University of California, San Francisco 17 yo male, DVT

More information

Ultrasound as a Tool for Preoperative Planning, Monitoring, and Interventions in Dialysis Arteriovenous Access

Ultrasound as a Tool for Preoperative Planning, Monitoring, and Interventions in Dialysis Arteriovenous Access Vascular and Interventional Radiology Review Shenoy and Darcy Ultrasound in Dialysis Interventions Vascular and Interventional Radiology Review FOUS ON: Surendra Shenoy 1 Michael Darcy 2 Shenoy S, Darcy

More information

Mechanical thrombectomy in acute thrombosis of dialysis fistulas: a multi-center study

Mechanical thrombectomy in acute thrombosis of dialysis fistulas: a multi-center study Mechanical thrombectomy in acute thrombosis of dialysis fistulas: a multi-center study Clément Marcelin 1 Y Le Bras 1, MD, F. Petitpierre 1, MD, N. Grenier 1, MD PHD, J V D Berg MD PHD 3, B Huasen 2, MD

More information

Drug Eluting Balloon for AVF Angioplasty : Does it work?

Drug Eluting Balloon for AVF Angioplasty : Does it work? Drug Eluting Balloon for AVF Angioplasty : Does it work? Dr Kiang Hiong TAY (MBBS, FRCR, FAMS, FSIR) Head & Senior Consultant, Dept of Diagnostic Radiology, Singapore General Hospital Director Interventional

More information

ASDIN 7th Annual Scientific Meeting DISCLOSURES TECHNICAL CONSIDERATIONS TECHNICAL CONSIDERATIONS UTILITY OF ULTRASOUND IN EVALUATING ACCESS

ASDIN 7th Annual Scientific Meeting DISCLOSURES TECHNICAL CONSIDERATIONS TECHNICAL CONSIDERATIONS UTILITY OF ULTRASOUND IN EVALUATING ACCESS DISCLOSURES UTILITY OF ULTRASOUND IN EVALUATING ACCESS DYSFUNCTION None Vandana Dua Niyyar, MD Assistant Professor of Medicine, Division of Nephrology, Emory University UTILITY OF ULTRASOUND IN ACCESS

More information

Cephalic Arch Stenosis: A unique entity

Cephalic Arch Stenosis: A unique entity Cephalic Arch Stenosis: A unique entity Arif Asif, M.D. Professor of Medicine Director, Interventional Nephrology University of Miami, Miami, FL PUMP Kian K, Asif A: Semin Dial 2008 Prevalence of CAS 39%

More information

Surgical Options in Thrombectomy for Non-Surgeons

Surgical Options in Thrombectomy for Non-Surgeons Surgical Options in Thrombectomy for Non-Surgeons Shouwen Wang, MD, PhD, FASDIN AKDHC Ambulatory Surgery Center Arizona Kidney Disease and Hypertension Center Phoenix, Arizona Disclosure No relevant financial

More information

Covered Stent angioplasty for iliac artery in-stent restenosis: Midterm Results

Covered Stent angioplasty for iliac artery in-stent restenosis: Midterm Results Covered Stent angioplasty for iliac artery in-stent restenosis: Midterm Results Poster No.: C-0510 Congress: ECR 2012 Type: Scientific Exhibit Authors: A. Chatziioannou 1, K. Palialexis 1, K. Katsenis

More information

Current Status and Limitations in the Treatment of Femoropopliteal In-Stent Restenosis

Current Status and Limitations in the Treatment of Femoropopliteal In-Stent Restenosis Current Status and Limitations in the Treatment of Femoropopliteal In-Stent Restenosis Osamu Iida, MD From the Kansai Rosai Hospital Cardiovascular Center, Amagasaki City, Japan. ABSTRACT: Approximately

More information

Complex Iliocaval Reconstruction PNEC. Seattle WA. Bill Marston MD Professor, Div of Vascular Surgery University of N.

Complex Iliocaval Reconstruction PNEC. Seattle WA. Bill Marston MD Professor, Div of Vascular Surgery University of N. Complex Iliocaval Reconstruction 2017 PNEC. Seattle WA Bill Marston MD Professor, Div of Vascular Surgery University of N. Carolina DISCLOSURES William Marston, MD Consultant/Advisory Board: Veniti, Cardinal

More information

Percutaneous and Surgical Treatments

Percutaneous and Surgical Treatments AVG Pseudoaneurysms Percutaneous and Surgical Treatments Marius Florescu M.D. Feb. 2015 ASDIN DEFINITION AVG Pseudoaneurysm Formation Incidence AVG Pseudoaneurysm incidence rate ranges between 2% and 10%

More information

Long-term outcomes of primary angioplasty and primary stenting of central venous stenosis in hemodialysis patients

Long-term outcomes of primary angioplasty and primary stenting of central venous stenosis in hemodialysis patients From the Society for Vascular Surgery Long-term outcomes of primary angioplasty and primary stenting of central venous stenosis in hemodialysis patients Andrew M. Bakken, MD, a Clinton D. Protack, BS,

More information

Distal Hypoperfusion Ischemic Syndrome (DHIS)

Distal Hypoperfusion Ischemic Syndrome (DHIS) Pathophysiology Traditional View ( Steal Syndrome ) Distal Hypoperfusion Ischemic Syndrome (DHIS) Steven Wu, MD Director of Interventional Nephrology Massachusetts General Hospital Harvard Medical School

More information

A Practical Review of the Use of Stents for the Maintenance of Hemodialysis Access

A Practical Review of the Use of Stents for the Maintenance of Hemodialysis Access How I Do It 217 A Practical Review of the Use of Stents for the Maintenance of Hemodialysis Access Michael Ginsburg, MD 1 Jonathan M. Lorenz, MD 2 Sean P. Zivin, MD 3 Steven Zangan, MD 2 Don Martinez,

More information

ASDIN 7th Annual Scientific Meeting

ASDIN 7th Annual Scientific Meeting Reported incidence 1-20% Loay Salman, MD Assistant Professor of Medicine University of Miami Miller School of Medicine Tordoir et al. J Vasc Endovasc Sur. 2004 Morsy et al. J Surg Res. 1998 Haimov et al.

More information

DCB in the treatment of av-accessa single center prospective study

DCB in the treatment of av-accessa single center prospective study DCB in the treatment of av-accessa single center prospective study Dr. med. Tobias Steinke Schön Klinik Fachzentrum Gefäßchirurgie, Düsseldorf Disclosure Speaker name: Dr. med. Tobias Steinke I have the

More information

Selection of Permanent Hemodialysis Vascular Access

Selection of Permanent Hemodialysis Vascular Access Selection of Permanent Hemodialysis Vascular Access TABLE OF CONTENTS 1.0 Scope...1 2.0 Recommendations & Rationale... 2 3.0 References... 3 4.0 Sponsors... 9 5.0 Effective Date... 10 Appendix 1: Key Elements

More information

Inflow stenosis in arteriovenous fistulas and grafts: A multicenter, prospective study

Inflow stenosis in arteriovenous fistulas and grafts: A multicenter, prospective study Kidney International, Vol. 67 (2005), pp. 1986 1992 Inflow stenosis in arteriovenous fistulas and grafts: A multicenter, prospective study ARIFASIF, FLORIN N. GADALEAN, DONNA MERRILL, GAUTAM CHERLA, CRISTIAN

More information

Lessons & Perspectives: What is the role of Cryoplasty in SFA Intervention?

Lessons & Perspectives: What is the role of Cryoplasty in SFA Intervention? Lessons & Perspectives: What is the role of Cryoplasty in SFA Intervention? Michael Wholey, MD, MBA San Antonio, TX USA 19/06/2009 at 09:35 during 4mn as a Speaker Session: Improving Femoral Artery Recanalization

More information

Treating In-Stent Restenosis with Brachytherapy: Does it Actually Work?

Treating In-Stent Restenosis with Brachytherapy: Does it Actually Work? Treating In-Stent Restenosis with Brachytherapy: Does it Actually Work? Matthew T. Menard, M.D. Brigham and Women s Hospital Pacific Northwest Endovascular Conference June 15, 2018 DISCLOSURE Matthew Menard,

More information

2 Aortic Arch Debranching UCSF Vascular Symposium /14/16. J Endovasc Ther 2002;9:suppl 2; II98 105

2 Aortic Arch Debranching UCSF Vascular Symposium /14/16. J Endovasc Ther 2002;9:suppl 2; II98 105 How I Do It: Aortic Arch Debranching Exposures, Tunnels and Techniques Warren Gasper MD Assistant Professor of Surgery UCSF Vascular Surgery No disclosures 2 Aortic Arch Debranching UCSF Vascular Symposium

More information

Complicated emergent endovascular repair of a life-threatening bilateral internal jugular vein occlusion

Complicated emergent endovascular repair of a life-threatening bilateral internal jugular vein occlusion Complicated emergent endovascular repair of a life-threatening bilateral internal jugular vein occlusion Stephanie Kwei, MD, Takao Ohki, MD, Johnathan eitler, MD, and Frank J. Veith, MD, ronx, NY 62-year-old

More information

Chronic Iliocaval Venous Occlusive Disease

Chronic Iliocaval Venous Occlusive Disease none Chronic Iliocaval Venous Occlusive Disease David Rigberg, M.D. Clinical Professor of Surgery Division of Vascular Surgery University of California Los Angeles Chronic Venous Occlusive Disease Chronic

More information